Key facts
- This page summarizes Jeffrey Scott Sherman's Form 4 filing for NEOGENOMICS INC (NEO).
- 6 reported transactions and 10 derivative rows are listed below.
- Accepted by SEC: 24 Feb 2026, 16:15.
Jeffrey Scott Sherman - 21 Feb 2026 Form 4 Insider Report for NEOGENOMICS INC (NEO)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- NEO
- Reported as of
- 21 Feb 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 24 Feb 2026, 16:15:10 UTC
- Prior SEC filing
- 09 Dec 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ali Olivo, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jeffrey Scott Sherman filed Form 4 for NEOGENOMICS INC (NEO) on 24 Feb 2026.
Change
- Previous filing in this sequence was filed on 09 Dec 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001463145
Primary reporting owner
Sherman Jeffrey Scott
- Relationship
- Chief Financial Officer
- Address
- 9490 NEOGENOMICS WAY, FORT MYERS
- Signature
- /s/ Ali Olivo, Attorney-in-Fact
- Signature date
- 24 Feb 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NEO
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +42,158
- Change %
- +24%
- Price
- $0.000000
- Shares after
- 218,986
- Date
- 21 Feb 2026
- Ownership
- Direct
- Footnotes
- F1, F2
NEO
transaction
Common Stock
Tax liability
- Transaction value
- $0
- Shares
- -10,729
- Change %
- -4.9%
- Price
- $0.000000
- Shares after
- 208,257
- Date
- 21 Feb 2026
- Ownership
- Direct
- Footnotes
- F3
NEO
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +15,535
- Change %
- +7.5%
- Price
- $0.000000
- Shares after
- 223,792
- Date
- 23 Feb 2026
- Ownership
- Direct
- Footnotes
- F1
NEO
transaction
Common Stock
Tax liability
- Transaction value
- $0
- Shares
- -3,783
- Change %
- -1.7%
- Price
- $0.000000
- Shares after
- 220,009
- Date
- 23 Feb 2026
- Ownership
- Direct
- Footnotes
- F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NEO
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -42,158
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 84,318
- Date
- 21 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 42,158
- Exercise price
- $0.000000
- Footnotes
- F4, F5
NEO
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -15,535
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 15,536
- Date
- 23 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 15,535
- Exercise price
- $0.000000
- Footnotes
- F5, F6
NEO
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 249,169
- Date
- 21 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 249,169
- Exercise price
- $11.62
- Footnotes
- F7
NEO
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 73,016
- Date
- 21 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 73,016
- Exercise price
- $19.65
- Footnotes
- F8
NEO
holding
Derivative
Restricted Stock Unit
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 13,006
- Date
- 21 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 13,006
- Exercise price
- $0.000000
- Footnotes
- F5, F9
NEO
holding
Derivative
Performance Stock Unit
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 39,016
- Date
- 21 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 39,016
- Exercise price
- $0.000000
- Footnotes
- F5, F10
NEO
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 77,913
- Date
- 21 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 77,913
- Exercise price
- $16.45
- Footnotes
- F11
NEO
holding
Derivative
Performance Stock Unit
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 46,606
- Date
- 21 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 46,606
- Exercise price
- $0.000000
- Footnotes
- F5, F12
NEO
holding
Derivative
Restricted Stock Unit
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 59,382
- Date
- 21 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 59,382
- Exercise price
- $0.000000
- Footnotes
- F5
NEO
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 214,900
- Date
- 21 Feb 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 214,900
- Exercise price
- $13.05
- Footnotes
- F13, F14
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 14 footnotes
Footnote F1
Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.
Footnote F2
This balance includes 434 shares that were acquired pursuant to NeoGenomics' Employee Stock Purchase Plan. The shares were acquired in transactions exempt from Section 16b-3.
Footnote F3
Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.
Footnote F4
On February 21, 2025, Mr. Sherman was granted 126,476 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
Footnote F5
Once vested, the shares of common stock are not subject to expiration.
Footnote F6
On February 23, 2024, Mr. Sherman was granted 46,606 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
Footnote F7
On December 5, 2022, Mr. Sherman was granted 249,169 stock options. The options vest ratably over four years with the first tranche vesting on December 7, 2023.
Footnote F8
On May 11, 2023, Mr. Sherman was granted 73,016 stock options. The options vest ratably over the first three anniversary dates of the grant date.
Footnote F9
On May 11, 2023, Mr. Sherman was granted 39,016 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
Footnote F10
On May 11, 2023, Mr. Sherman was granted 39,016 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 58,524. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company.
Footnote F11
On February 23, 2024, Mr. Sherman was granted 77,913 stock options. The options vest ratably over the first three anniversary dates of the grant date.
Footnote F12
On February 23, 2024, Mr. Sherman was granted 46,606 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 69,910. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.
Footnote F13
This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 20, 2025 and multiplied by 110%.
Footnote F14
On February 21, 2025, Mr. Sherman was granted 214,900 stock options. The options vest ratably over the first three anniversary dates of the grant date.